Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 11:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 192 matching trials from the live ClinicalTrials.gov search.
Filters: Condition: Term Infant Clear all
Completed Phase 3 Interventional

Whole-Body Cooling for Birth Asphyxia in Term Infants

NCT00005772
View directory record Official record
Conditions
Infant, Newborn, Hypoxia-Ischemia, Brain
Interventions
Induced hypothermia, Control
Device
Lead sponsor
NICHD Neonatal Research Network
Network
Eligibility
Up to 6 Hours
Enrollment
208 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
1999 – 2010
U.S. locations
16
States / cities
Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 13 more
Source: ClinicalTrials.gov public record
Updated Mar 22, 2019 · Synced Oct 27, 2026, 11:43 AM EDT
Recruiting No phase listed Observational

Motor-voice Assessment in Infants (MAMI)

NCT06807203
View directory record Official record
Conditions
Cerebral Palsy Infantile, Pre-Term, Motor Delay, Neurodevelopmental Disorders, Autism Spectrum Disorder
Interventions
Behavioral observation
Other
Lead sponsor
Ohio State University
Other
Eligibility
Up to 10 Days
Enrollment
46 participants
Timeline
2025 – 2030
U.S. locations
1
States / cities
Columbus, Ohio
Source: ClinicalTrials.gov public record
Updated Mar 27, 2026 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Not applicable Interventional

Soy Formula Feedings in Healthy, Term Infants

NCT02456831
View directory record Official record
Conditions
Gastrointestinal Tolerance
Interventions
Experimental Infant Formula 1, Experimental Infant Formula 2, Experimental Infant Formula 3, Active Comparator: Control Infant Formula
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
2 Weeks to 9 Weeks
Enrollment
115 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
1992 – 1994
U.S. locations
7
States / cities
Little Rock, Arkansas • Aurora, Illinois • Owensboro, Kentucky + 4 more
Source: ClinicalTrials.gov public record
Updated May 29, 2015 · Synced Oct 27, 2026, 11:43 AM EDT
Recruiting Not applicable Interventional Accepts healthy volunteers

ShotBlocker During Intramuscular Injection Randomized Control Trial

NCT06624176
View directory record Official record
Conditions
Neonatal Pain
Interventions
Bionix ShotBlocker, Swaddling, Sucrose administration, Masimo Rad-97 Oximeter probe
Device · Other
Lead sponsor
Lauren Fortier
Other
Eligibility
37 Weeks to 42 Weeks
Enrollment
200 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2027
U.S. locations
1
States / cities
Worcester, Massachusetts
Source: ClinicalTrials.gov public record
Updated Oct 20, 2026 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Therapist Education and Massage for Parent Infant-Outcomes

NCT04121897
View directory record Official record
Conditions
Parent-Child Relations, Parents, Extreme Prematurity
Interventions
Therapist Education and Massage for Parents of Extremely Preterm Infants
Other
Lead sponsor
University of North Carolina, Chapel Hill
Other
Eligibility
Not listed
Enrollment
68 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019 – 2022
U.S. locations
1
States / cities
Chapel Hill, North Carolina
Source: ClinicalTrials.gov public record
Updated May 6, 2023 · Synced Oct 27, 2026, 11:43 AM EDT
Completed No phase listed Observational Accepts healthy volunteers

Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants

NCT00833222
View directory record Official record
Conditions
Premature Birth
Interventions
Not listed
Lead sponsor
University of Utah
Other
Eligibility
31 Weeks to 42 Weeks
Enrollment
72 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2008 – 2012
U.S. locations
1
States / cities
Salt Lake City, Utah
Source: ClinicalTrials.gov public record
Updated Dec 26, 2017 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Phase 3 Interventional Results available

A Study Evaluating the Long-term Safety of VX-445 Combination Therapy

NCT04043806
View directory record Official record
Conditions
Cystic Fibrosis
Interventions
ELX/TEZ/IVA, IVA
Drug
Lead sponsor
Vertex Pharmaceuticals Incorporated
Industry
Eligibility
12 Years and older
Enrollment
458 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2022
U.S. locations
46
States / cities
Birmingham, Alabama • Palo Alto, California • Aurora, Colorado + 42 more
Source: ClinicalTrials.gov public record
Updated Jul 6, 2023 · Synced Oct 27, 2026, 11:43 AM EDT
Withdrawn Not applicable Interventional Accepts healthy volunteers

Growth and Tolerance of Healthy Term Infants Fed Cow's Milk-Based Infant Formulas

NCT02860026
View directory record Official record
Conditions
Growth
Interventions
Marketed cow's milk-based infant formula, Cow's milk-based infant formula with added nutrients
Other
Lead sponsor
Mead Johnson Nutrition
Industry
Eligibility
10 Days to 14 Days
Healthy volunteers
Accepts healthy volunteers
Timeline
2016 – 2018
U.S. locations
17
States / cities
Birmingham, Alabama • Dothan, Alabama • Fayetteville, Arkansas + 14 more
Source: ClinicalTrials.gov public record
Updated May 31, 2017 · Synced Oct 27, 2026, 11:43 AM EDT
Recruiting No phase listed Observational

Long-Term Outcomes of Children With Congenital CMV in New York State

NCT06226558
View directory record Official record
Conditions
Congenital CMV Infection, Sensorineural Hearing Loss
Interventions
Not listed
Lead sponsor
Stony Brook University
Other
Eligibility
0 Days to 1 Year
Enrollment
1,000 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2026
U.S. locations
1
States / cities
Stony Brook, New York
Source: ClinicalTrials.gov public record
Updated May 13, 2025 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Formula Tolerance of Term Infants

NCT04915937
View directory record Official record
Conditions
Gastro-Intestinal Tolerance
Interventions
Study Infant Formula
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
7 Days to 65 Days
Enrollment
45 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2021 – 2022
U.S. locations
12
States / cities
Phoenix, Arizona • Miami, Florida • Macon, Georgia + 9 more
Source: ClinicalTrials.gov public record
Updated Dec 20, 2022 · Synced Oct 27, 2026, 11:43 AM EDT
Terminated Phase 3 Interventional Results available

Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome

NCT00004500
View directory record Official record
Conditions
Meconium Aspiration
Interventions
Lucinactant, Standard Care
Drug · Other
Lead sponsor
Windtree Therapeutics
Industry
Eligibility
Up to 48 Hours
Enrollment
69 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2000 – 2004
U.S. locations
1
States / cities
Warrington, Pennsylvania
Source: ClinicalTrials.gov public record
Updated May 3, 2012 · Synced Oct 27, 2026, 11:43 AM EDT
Recruiting No phase listed Observational

Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

NCT06258902
View directory record Official record
Conditions
Pregnancy Related
Interventions
Not listed
Lead sponsor
Ipsen
Industry
Eligibility
Female only
Enrollment
20 participants
Timeline
2023 – 2032
U.S. locations
1
States / cities
Wilmington, North Carolina
Source: ClinicalTrials.gov public record
Updated Oct 23, 2026 · Synced Oct 27, 2026, 11:43 AM EDT
Terminated Not applicable Interventional Accepts healthy volunteers

Gastrointestinal Tract Microbiome in Healthy Term Infants Receiving Mother'S-own Breast Milk or Cow's Milk-based Infant Formulas

NCT04059666
View directory record Official record
Conditions
Gastrointestinal Microbiome
Interventions
Investigational, Control
Other
Lead sponsor
Mead Johnson Nutrition
Industry
Eligibility
7 Days to 18 Days
Enrollment
57 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019 – 2022
U.S. locations
5
States / cities
Birmingham, Alabama • Altamonte Springs, Florida • Owensboro, Kentucky + 2 more
Source: ClinicalTrials.gov public record
Updated Aug 25, 2022 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Phase 3 Interventional Results available

Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis

NCT01555957
View directory record Official record
Conditions
Parenteral Nutrition Associated Cholestasis
Interventions
intravenous lipid
Drug
Lead sponsor
University of Rochester
Other
Eligibility
Up to 72 Hours
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2019
U.S. locations
1
States / cities
Rochester, New York
Source: ClinicalTrials.gov public record
Updated Dec 3, 2020 · Synced Oct 27, 2026, 11:43 AM EDT
Completed No phase listed Observational Results available

CoolCap Followup Study-Coordination of Participating Centers

NCT00581581
View directory record Official record
Conditions
Neonatal Encephalopathy
Interventions
Not listed
Lead sponsor
University of Rochester
Other
Eligibility
6 Years to 8 Years
Enrollment
62 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2009
U.S. locations
1
States / cities
Rochester, New York
Source: ClinicalTrials.gov public record
Updated Mar 8, 2013 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

NCT04218929
View directory record Official record
Conditions
Infants, Newborn
Interventions
Study Formula (SF), Comparator Formula (CF)
Other
Lead sponsor
ByHeart
Industry
Eligibility
0 Days to 14 Days
Enrollment
311 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019 – 2021
U.S. locations
27
States / cities
Birmingham, Alabama • Tucson, Arizona • Jonesboro, Arkansas + 24 more
Source: ClinicalTrials.gov public record
Updated Jun 30, 2021 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Phase 3 Interventional

Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism

NCT03941236
View directory record Official record
Conditions
Congenital Hyperinsulinism
Interventions
dasiglucagon
Drug
Lead sponsor
Zealand Pharma
Industry
Eligibility
5 Weeks to 13 Years
Enrollment
42 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2026
U.S. locations
3
States / cities
Aurora, Colorado • Philadelphia, Pennsylvania • Fort Worth, Texas
Source: ClinicalTrials.gov public record
Updated Aug 3, 2026 · Synced Oct 27, 2026, 11:43 AM EDT
Active, not recruiting Early Phase 1 Interventional

Respiratory Transition Without Continuous Positive Airway Pressure

NCT07390812
View directory record Official record
Conditions
Mild Respiratory Distress
Interventions
Transition without Continuous Positive Airway Pressure (CPAP), CPAP
Other
Lead sponsor
Hackensack Meridian Health
Other
Eligibility
37 Weeks to 41 Weeks
Enrollment
22 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2026
U.S. locations
1
States / cities
Hackensack, New Jersey
Source: ClinicalTrials.gov public record
Updated Feb 27, 2026 · Synced Oct 27, 2026, 11:43 AM EDT
Completed No phase listed Observational

Work of Breathing in Term Infants

NCT05209269
View directory record Official record
Conditions
Work of Breathing, Term Infant
Interventions
Work of breathing observation
Other
Lead sponsor
Christiana Care Health Services
Other
Eligibility
1 Day to 1 Week
Enrollment
31 participants
Timeline
2022 – 2023
U.S. locations
1
States / cities
Newark, Delaware
Source: ClinicalTrials.gov public record
Updated Sep 11, 2023 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Phase 4 Interventional

Inhaled Nitric Oxide by Oxygen Hood in Neonates

NCT00732537
View directory record Official record
Conditions
Respiratory Failure, Infant, Persistent Fetal Circulation
Interventions
inhaled Nitric Oxide, Oxygen (>90% by hood) - standard therapy
Drug
Lead sponsor
University of Alabama at Birmingham
Other
Eligibility
1 Hour to 1 Week
Enrollment
8 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
1999 – 2005
U.S. locations
1
States / cities
Birmingham, Alabama
Source: ClinicalTrials.gov public record
Updated Aug 12, 2008 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term

NCT00936637
View directory record Official record
Conditions
Growth
Interventions
Extensively hydrolyzed infant formula
Other
Lead sponsor
Perrigo Nutritionals
Industry
Eligibility
1 Day to 21 Days
Enrollment
35 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2007 – 2008
U.S. locations
1
States / cities
Charlottesville, Virginia
Source: ClinicalTrials.gov public record
Updated Jul 10, 2009 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Not applicable Interventional Results available

Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients

NCT01784419
View directory record Official record
Conditions
Cystic Fibrosis
Interventions
ivacaftor, Placebo
Drug
Lead sponsor
University of California, San Francisco
Other
Eligibility
6 Years and older
Enrollment
10 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2015
U.S. locations
1
States / cities
San Francisco, California
Source: ClinicalTrials.gov public record
Updated Sep 29, 2020 · Synced Oct 27, 2026, 11:43 AM EDT
Completed Phase 1 Interventional

Open-label Study of Inhaled RVT-1601 in Preterm Infants

NCT04007120
View directory record Official record
Conditions
Respiratory Morbidities of Prematurity (RMP)
Interventions
RVT-1601
Drug
Lead sponsor
Respivant Sciences GmbH
Industry
Eligibility
32 Months to 35 Months
Enrollment
8 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2020
U.S. locations
1
States / cities
San Diego, California
Source: ClinicalTrials.gov public record
Updated Jun 4, 2020 · Synced Oct 27, 2026, 11:43 AM EDT
Recruiting Not applicable Interventional

Skin-to-skin Care Using the Skincubator: Feasibility and Safety Trial

NCT07721662
View directory record Official record
Conditions
Skin to Skin Care for Preterm Infants
Interventions
Skincubator-supported SSC, t-SSC
Device · Other
Lead sponsor
The University of Texas Health Science Center, Houston
Other
Eligibility
Up to 6 Days
Enrollment
60 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
1
States / cities
Houston, Texas
Source: ClinicalTrials.gov public record
Updated Aug 21, 2026 · Synced Oct 27, 2026, 11:43 AM EDT